Mirum Pharmaceuticals, Inc.
MIRMNASDAQHealthcare● Active
$93.59
+$0.11(+0.11%)
Market Cap$4.7B
P/E Ratio—
52W High$114.99
52W Low$47.15
Mirum Pharmaceuticals, Inc. (MIRM) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MIRM · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.02B) | ($0.09B) | ($0.16B) | ($0.14B) | ($0.08B) |
| Depreciation & Amort. | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.07B | $0.05B | $0.04B | $0.03B | $0.02B |
| Change in Working Capital | ($0.02B) | $0.02B | ($0.02B) | ($0.02B) | $0.02B |
| Net Cash from Operations | $0.06B | $0.01B | ($0.07B) | ($0.12B) | ($0.13B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.02B) | ($0.00B) | ($0.02B) |
| Purchases of Investments | ($0.10B) | ($0.09B) | ($0.03B) | ($0.13B) | ($0.20B) |
| Sales of Investments | $0.07B | $0.02B | $0.15B | $0.14B | $0.16B |
| Net Cash from Investing | ($0.02B) | ($0.09B) | ($0.11B) | $0.01B | $0.05B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.31B | $0.00B | $0.00B |
| Net Cash from Financing | $0.04B | $0.02B | $0.34B | $0.11B | $0.07B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.05B | $0.01B | ($0.09B) | ($0.12B) | ($0.15B) |
| FCF Margin %(computed) | 10.53% | 2.77% | -48.85% | -156.26% | -793.09% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Mirum Pharmaceuticals, Inc. data
About Mirum Pharmaceuticals, Inc. (MIRM) Cash Flow Statement
Mirum Pharmaceuticals, Inc. generated operating cash flow of $0.06B and free cash flow of $0.05B for 2025 — a FCF margin of 10.53%. Capital expenditure was ($0.00B).
Frequently asked questions
MIRM · 4 questionsMirum Pharmaceuticals, Inc. generated free cash flow of $0.05B for 2025, up 488.0% year-over-year.
MIRM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10